Latest Insider Transactions at Arcutis Biotherapeutics, Inc. (ARQT)
This section provides a real-time view of insider transactions for Arcutis Biotherapeutics, Inc. (ARQT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcutis Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcutis Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Sue Jean Lin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,312
+48.32%
|
-
|
|
Jun 01
2022
|
Howard G. Welgus Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,312
+2.26%
|
-
|
|
Jun 01
2022
|
Halley E Gilbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,312
+50.0%
|
-
|
|
Jun 01
2022
|
Bhaskar Chaudhuri Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,312
+0.51%
|
-
|
|
Jun 01
2022
|
Terrie Curran Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,312
+50.0%
|
-
|
|
Jun 01
2022
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.36%
|
$50,000
$20.62 P/Share
|
|
Jun 01
2022
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.34%
|
$2,500
$1.68 P/Share
|
|
May 27
2022
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+21.15%
|
-
|
|
May 05
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.15%
|
$21,000
$21.76 P/Share
|
|
May 02
2022
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.36%
|
$50,000
$20.44 P/Share
|
|
May 02
2022
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.68%
|
$2,500
$1.13 P/Share
|
|
Apr 21
2022
|
David W Osborne Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,197
-0.85%
|
$43,940
$20.42 P/Share
|
|
Apr 08
2022
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
200,000
-10.51%
|
$4,000,000
$20.71 P/Share
|
|
Apr 07
2022
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
344,996
-14.16%
|
$6,899,920
$20.66 P/Share
|
|
Apr 06
2022
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
333,204
-11.39%
|
$6,664,080
$20.69 P/Share
|
|
Apr 05
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.15%
|
$21,000
$21.43 P/Share
|
|
Apr 01
2022
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
7,500
-3.96%
|
$150,000
$20.02 P/Share
|
|
Apr 01
2022
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.81%
|
$0
$0.58 P/Share
|
|
Mar 23
2022
|
Patricia A. Turney SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
25,328
+30.98%
|
$151,968
$6.52 P/Share
|
|
Mar 09
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
300
-0.05%
|
$5,100
$17.0 P/Share
|
|
Mar 07
2022
|
David W Osborne Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
28
-0.01%
|
$448
$16.44 P/Share
|
|
Mar 07
2022
|
Patricia A. Turney SVP, Operations |
SELL
Open market or private sale
|
Direct |
30
-0.1%
|
$480
$16.44 P/Share
|
|
Mar 07
2022
|
Scott L Burrows Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10
-0.03%
|
$160
$16.44 P/Share
|
|
Mar 07
2022
|
Kenneth A. Lock Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
30
-0.07%
|
$480
$16.44 P/Share
|
|
Mar 07
2022
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
30
-0.07%
|
$480
$16.44 P/Share
|
|
Mar 07
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
770
-0.06%
|
$12,320
$16.78 P/Share
|
|
Mar 07
2022
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
700
+0.11%
|
$700
$1.68 P/Share
|
|
Mar 04
2022
|
David W Osborne Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
828
-0.32%
|
$13,248
$16.86 P/Share
|
|
Mar 04
2022
|
Patricia A. Turney SVP, Operations |
SELL
Open market or private sale
|
Direct |
993
-3.09%
|
$15,888
$16.86 P/Share
|
|
Mar 04
2022
|
Scott L Burrows Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
293
-0.82%
|
$4,688
$16.86 P/Share
|
|
Mar 04
2022
|
Kenneth A. Lock Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
993
-2.21%
|
$15,888
$16.86 P/Share
|
|
Mar 04
2022
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
981
-2.23%
|
$15,696
$16.86 P/Share
|
|
Mar 04
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,489
-0.38%
|
$39,824
$16.86 P/Share
|
|
Mar 03
2022
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,300
+50.0%
|
-
|
|
Mar 03
2022
|
David W Osborne Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,300
+4.86%
|
-
|
|
Mar 03
2022
|
Patricia A. Turney SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
13,300
+29.27%
|
-
|
|
Mar 03
2022
|
Scott L Burrows Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,300
+27.22%
|
-
|
|
Mar 03
2022
|
Kenneth A. Lock Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,300
+22.8%
|
-
|
|
Mar 03
2022
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,300
+50.0%
|
-
|
|
Mar 03
2022
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+28.78%
|
-
|
|
Mar 03
2022
|
Todd Franklin Watanabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,900
+9.65%
|
-
|
|
Mar 01
2022
|
Kenneth A. Lock Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
935
-2.86%
|
$15,895
$17.75 P/Share
|
|
Mar 01
2022
|
Patricia A. Turney SVP, Operations |
SELL
Open market or private sale
|
Direct |
936
-4.73%
|
$15,912
$17.75 P/Share
|
|
Mar 01
2022
|
Scott L Burrows Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
420
-1.85%
|
$7,140
$17.75 P/Share
|
|
Mar 01
2022
|
David W Osborne Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
775
-0.31%
|
$13,175
$17.75 P/Share
|
|
Mar 01
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,153
-0.36%
|
$36,601
$17.75 P/Share
|
|
Feb 09
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$17,000
$17.0 P/Share
|
|
Feb 09
2022
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Jan 05
2022
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.06%
|
$21,000
$21.86 P/Share
|
|
Jan 05
2022
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|